Compare $ALGN vs $HAE | Chartloom

Compare

$ALGN vs $HAE

Align Technology Inc · Haemonetics Corp

ALGN

Align Technology Inc

HAE

Haemonetics Corp

Compare $ALGN vs $HAE

Comparing Align Technology Inc and Haemonetics Corp

ALGNAlign Technology Inc

HAEHaemonetics Corp

ALGNAlign Technology Inc

Market cap

$10.22B

P/E (TTM)

24.68x

Forward P/E (NTM)

11.84x

Forward P/S (NTM)

2.37x

Rev growth (TTM)

4.4%

YTD performance

-8.5%

52W performance

7.2%

FCF yield

6.2%

HAEHaemonetics Corp

Market cap

$5.39B

P/E (TTM)

56.34x

Forward P/E (NTM)

21.33x

Forward P/S (NTM)

3.72x

Rev growth (TTM)

0.4%

YTD performance

48.4%

52W performance

132.8%

FCF yield

4.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALGN

HAE

Detailed metrics comparison

ALGN

Align Technology Inc

HAE

Haemonetics Corp

Market Cap

ALGN$10.22B

HAE$5.39B

Enterprise Value

ALGN$9.13B

HAE$6.35B

Price

ALGN$142.71

HAE$118.69

P/E Ratio

ALGN24.68x

HAE56.34x

P/S Ratio

ALGN2.47x

HAE3.99x

EV/Sales

ALGN2.21x

HAE4.69x

EV/EBITDA

ALGN9.61x

HAE17.94x

P/B Ratio

ALGN2.41x

HAE5.69x

P/FCF Ratio

ALGN16.13x

HAE22.00x

EV/FCF

ALGN14.42x

HAE25.88x

PEG Ratio

ALGN2.88x

HAEN/A

Forward P/E (NTM)

ALGN11.84x

HAE21.33x

Forward P/S (NTM)

ALGN2.37x

HAE3.72x

Revenue (TTM)

ALGN$4.14B

HAE$1.35B

Revenue Growth (YoY)

ALGN4.4%

HAE0.4%

Forward Rev Growth

ALGN4.1%

HAE5.2%

Gross Margin (TTM)

ALGN69.0%

HAE59.1%

Operating Margin (TTM)

ALGN13.2%

HAE11.9%

EBITDA Margin (TTM)

ALGN22.9%

HAE26.2%

Net Margin (TTM)

ALGN10.0%

HAE7.1%

FCF Margin (TTM)

ALGN15.3%

HAE18.1%

Net Income (TTM)

ALGN$414M

HAE$96M

FCF (TTM)

ALGN$634M

HAE$245M

EPS (TTM)

ALGN$5.78

HAE$2.11

ROE (TTM)

ALGN10.1%

HAE11.3%

ROA (TTM)

ALGN6.6%

HAE4.0%

ROIC (TTM)

ALGN10.1%

HAE4.7%

Cash

ALGN$1.09B

HAE$223M

Debt

ALGN$0

HAE$1.17B

Net Cash/Debt

ALGN$1.09B

HAE$-951M

Current Ratio (TTM)

ALGN1.40x

HAE3.08x

Quick Ratio (TTM)

ALGN1.23x

HAE1.67x

Debt/Equity (TTM)

ALGN0.00x

HAE1.40x

Debt/Assets (TTM)

ALGN0.0%

HAE0.0%

Interest Coverage (TTM)

ALGNN/A

HAEN/A

Net Debt/EBITDA (TTM)

ALGN0.00x

HAE0.00x

Beta

ALGN1.74

HAE0.62

52W Performance

ALGN7.2%

HAE132.8%

YTD Performance

ALGN-8.5%

HAE48.4%

% from 52W High

ALGN-28.8%

HAE-2.1%

% from 52W Low

ALGN14.3%

HAE146.4%

Asset Turnover (TTM)

ALGN0.66x

HAE0.56x

FCF Yield (TTM)

ALGN6.2%

HAE4.5%

Earnings Yield (TTM)

ALGN4.0%

HAE1.8%

Dividend Yield (TTM)

ALGNN/A

HAEN/A

Rule of 40

ALGN19.7

HAE18.6

EV/GP/RG

ALGN0.79

HAE1.08

Ticker research

View ALGN research View HAE research

Metric	ALGN Align Technology Inc	HAE Haemonetics Corp
Market & Valuation
Market Cap	$10.22B	$5.39B
Enterprise Value	$9.13B	$6.35B
Price	$142.71	$118.69
P/E Ratio	24.68x	56.34x
P/S Ratio	2.47x	3.99x
EV/Sales	2.21x	4.69x
EV/EBITDA	9.61x	17.94x
P/B Ratio	2.41x	5.69x
P/FCF Ratio	16.13x	22.00x
EV/FCF	14.42x	25.88x
PEG Ratio	2.88x	N/A
Forward P/E (NTM)	11.84x	21.33x
Forward P/S (NTM)	2.37x	3.72x
Revenue & Growth
Revenue (TTM)	$4.14B	$1.35B
Revenue Growth (YoY)	4.4%	0.4%
Forward Rev Growth	4.1%	5.2%
Profitability
Gross Margin (TTM)	69.0%	59.1%
Operating Margin (TTM)	13.2%	11.9%
EBITDA Margin (TTM)	22.9%	26.2%
Net Margin (TTM)	10.0%	7.1%
FCF Margin (TTM)	15.3%	18.1%
Net Income (TTM)	$414M	$96M
FCF (TTM)	$634M	$245M
EPS (TTM)	$5.78	$2.11
ROE (TTM)	10.1%	11.3%
ROA (TTM)	6.6%	4.0%
ROIC (TTM)	10.1%	4.7%
Financial Health
Cash	$1.09B	$223M
Debt	$0	$1.17B
Net Cash/Debt	$1.09B	$-951M
Current Ratio (TTM)	1.40x	3.08x
Quick Ratio (TTM)	1.23x	1.67x
Debt/Equity (TTM)	0.00x	1.40x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.74	0.62
52W Performance	7.2%	132.8%
YTD Performance	-8.5%	48.4%
% from 52W High	-28.8%	-2.1%
% from 52W Low	14.3%	146.4%
Efficiency & Yields
Asset Turnover (TTM)	0.66x	0.56x
FCF Yield (TTM)	6.2%	4.5%
Earnings Yield (TTM)	4.0%	1.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	19.7	18.6
EV/GP/RG	0.79	1.08
Ticker research	View ALGN research	View HAE research

Valuation

P/E Ratio

ALGN

24.68x

HAE

56.34x

P/S Ratio

ALGN

2.47x

HAE

3.99x

EV/FCF

ALGN

14.42x

HAE

25.88x

Growth & revenue

Revenue Growth TTM

ALGN

4.4%

HAE

0.4%

Forward Revenue Growth

HAE

5.2%

ALGN

4.1%

Profitability & performance

Gross Margin

ALGN

69.0%

HAE

59.1%

ROE

HAE

11.3%

ALGN

10.1%

FCF Yield %

ALGN

6.2%

HAE

4.5%

52-Week Performance

HAE

132.8%

ALGN

7.2%

Detailed metrics comparison

ALGN

Align Technology Inc

HAE

Haemonetics Corp

Market Cap

ALGN$10.22B

HAE$5.39B

Enterprise Value

ALGN$9.13B

HAE$6.35B

Price

ALGN$142.71

HAE$118.69

P/E Ratio

ALGN24.68x

HAE56.34x

P/S Ratio

ALGN2.47x

HAE3.99x

EV/Sales

ALGN2.21x

HAE4.69x

EV/EBITDA

ALGN9.61x

HAE17.94x

P/B Ratio

ALGN2.41x

HAE5.69x

P/FCF Ratio

ALGN16.13x

HAE22.00x

EV/FCF

ALGN14.42x

HAE25.88x

PEG Ratio

ALGN2.88x

HAEN/A

Forward P/E (NTM)

ALGN11.84x

HAE21.33x

Forward P/S (NTM)

ALGN2.37x

HAE3.72x

Revenue (TTM)

ALGN$4.14B

HAE$1.35B

Revenue Growth (YoY)

ALGN4.4%

HAE0.4%

Forward Rev Growth

ALGN4.1%

HAE5.2%

Gross Margin (TTM)

ALGN69.0%

HAE59.1%

Operating Margin (TTM)

ALGN13.2%

HAE11.9%

EBITDA Margin (TTM)

ALGN22.9%

HAE26.2%

Net Margin (TTM)

ALGN10.0%

HAE7.1%

FCF Margin (TTM)

ALGN15.3%

HAE18.1%

Net Income (TTM)

ALGN$414M

HAE$96M

FCF (TTM)

ALGN$634M

HAE$245M

EPS (TTM)

ALGN$5.78

HAE$2.11

ROE (TTM)

ALGN10.1%

HAE11.3%

ROA (TTM)

ALGN6.6%

HAE4.0%

ROIC (TTM)

ALGN10.1%

HAE4.7%

Cash

ALGN$1.09B

HAE$223M

Debt

ALGN$0

HAE$1.17B

Net Cash/Debt

ALGN$1.09B

HAE$-951M

Current Ratio (TTM)

ALGN1.40x

HAE3.08x

Quick Ratio (TTM)

ALGN1.23x

HAE1.67x

Debt/Equity (TTM)

ALGN0.00x

HAE1.40x

Debt/Assets (TTM)

ALGN0.0%

HAE0.0%

Interest Coverage (TTM)

ALGNN/A

HAEN/A

Net Debt/EBITDA (TTM)

ALGN0.00x

HAE0.00x

Beta

ALGN1.74

HAE0.62

52W Performance

ALGN7.2%

HAE132.8%

YTD Performance

ALGN-8.5%

HAE48.4%

% from 52W High

ALGN-28.8%

HAE-2.1%

% from 52W Low

ALGN14.3%

HAE146.4%

Asset Turnover (TTM)

ALGN0.66x

HAE0.56x

FCF Yield (TTM)

ALGN6.2%

HAE4.5%

Earnings Yield (TTM)

ALGN4.0%

HAE1.8%

Dividend Yield (TTM)

ALGNN/A

HAEN/A

Rule of 40

ALGN19.7

HAE18.6

EV/GP/RG

ALGN0.79

HAE1.08

Ticker research

View ALGN research View HAE research

Metric	ALGN Align Technology Inc	HAE Haemonetics Corp
Market & Valuation
Market Cap	$10.22B	$5.39B
Enterprise Value	$9.13B	$6.35B
Price	$142.71	$118.69
P/E Ratio	24.68x	56.34x
P/S Ratio	2.47x	3.99x
EV/Sales	2.21x	4.69x
EV/EBITDA	9.61x	17.94x
P/B Ratio	2.41x	5.69x
P/FCF Ratio	16.13x	22.00x
EV/FCF	14.42x	25.88x
PEG Ratio	2.88x	N/A
Forward P/E (NTM)	11.84x	21.33x
Forward P/S (NTM)	2.37x	3.72x
Revenue & Growth
Revenue (TTM)	$4.14B	$1.35B
Revenue Growth (YoY)	4.4%	0.4%
Forward Rev Growth	4.1%	5.2%
Profitability
Gross Margin (TTM)	69.0%	59.1%
Operating Margin (TTM)	13.2%	11.9%
EBITDA Margin (TTM)	22.9%	26.2%
Net Margin (TTM)	10.0%	7.1%
FCF Margin (TTM)	15.3%	18.1%
Net Income (TTM)	$414M	$96M
FCF (TTM)	$634M	$245M
EPS (TTM)	$5.78	$2.11
ROE (TTM)	10.1%	11.3%
ROA (TTM)	6.6%	4.0%
ROIC (TTM)	10.1%	4.7%
Financial Health
Cash	$1.09B	$223M
Debt	$0	$1.17B
Net Cash/Debt	$1.09B	$-951M
Current Ratio (TTM)	1.40x	3.08x
Quick Ratio (TTM)	1.23x	1.67x
Debt/Equity (TTM)	0.00x	1.40x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.74	0.62
52W Performance	7.2%	132.8%
YTD Performance	-8.5%	48.4%
% from 52W High	-28.8%	-2.1%
% from 52W Low	14.3%	146.4%
Efficiency & Yields
Asset Turnover (TTM)	0.66x	0.56x
FCF Yield (TTM)	6.2%	4.5%
Earnings Yield (TTM)	4.0%	1.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	19.7	18.6
EV/GP/RG	0.79	1.08
Ticker research	View ALGN research	View HAE research